Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Netherlands-Based Detact Diagnostics Plans Keene, New Hampshire, U.S. Headquarters

05/12/2022
Detact Diagnostics, a Netherlands-based life-sciences company that produces bacterial- and viral-detection solutions, will establish its U.S. headquarters and laboratories in Keene, New Hampshire.

The expansion is in partnership with the Hannah Grimes Center for Entrepreneurship, which provides resources for entrepreneurs and companies in the state’s rural Monadnock Region, and Keene State College, which will provide space for Detact Diagnostics to create a Clinical Laboratory Improvement Amendment or (CLIA)-certified laboratories as well as an expansive internship and employment program.

“With its easily accessible networking opportunities compared to larger markets, plus its life-sciences ecosystem and the support from Hannah Grimes, New Hampshire is the ideal destination for our U.S. expansion,” said Joost Gazendam, CEO of Detact Diagnostics. “From its proximity to the Manchester and Nashua areas, to its affordability, quality of life, and community connectivity, this rural region offers endless benefits that will allow us to continue to grow our company, educate a new generation of professionals and deploy life-changing technology.”

CLIA-certified laboratories are federally regulated sites that test human specimens to diagnose, prevent and treat disease. The lab space to be developed at Keene State College will be used for Detact Diagnostics’ on-site bacterial-detection platforms, which enable healthcare providers and food-processing professionals to detect the presence of virus and bacteria and allow for fast, affordable and precise treatment.

“I am happy to welcome Detact to New Hampshire’s growing life science community,” said New Hampshire Department of Business and Economic Affairs Commissioner Taylor Caswell. “In addition to the world-class technology being researched and implemented in our state, this expansion and partnership with Keene State College further demonstrates the value of our ‘triangle’ strategy (employer-academic center-government) to generate high tech investment statewide.”

The patented Detact Diagnostics platform technology called VIPER (Visualization by Infrared Peptide Reaction) involves the immediate release of a quenched Near Infrared (NIR) molecule from its peptide bond after contact with a specific bacteria/enzyme, which emits NIR-light (NIRL). The amount of light released determines the presence of bacteria or viruses. Due to its speed, precision and sensitivity, even with very diluted samples, the potential of this technology is superior compared to other testing products.

Share

Exclusive Research